Perrigo Starts Shipment of Generic Astepro

Perrigo Starts Shipment of Generic Astepro
Perrigo Starts Shipment of Generic Astepro

Perrigo announced that the FDA has granted final approval on its Abbreviated New Drug Application (ANDA) for Azelastine HCl Nasal Spray 0.15%, the generic version of Meda's Astepro. Astepro is indicated for seasonal and perennial allergic rhinitis in patients >12 years old.

RELATED: Rhinitis & Nasal Congestion Treatments

Azelastine HCl, a phthalazinone derivative, exhibits histamine H1-receptor antagonist activity in isolated tissues, animal models, and humans. Azelastine HCl is administered as a racemic mixture with no difference in pharmacologic activity noted between the enantiomers in in vitro studies. The major metabolite, desmethylazelastine, also possesses H1-receptor antagonist activity.

For more information call (866) 634-9120 or visit Perrigo.com.

Loading links....